AAP officials say the risk of cancer from newborn intramuscular vitamin K injections has not been proven, following a British study which linked leukemia to the practice.

Maintaining the position that vitamin K administration is vital in preventing a deficiency which may cause unexpected bleeding during the newborn period, Academy leaders have issued a policy on the practice based on findings of the AAP Vitamin K Ad Hoc Task Force. (See accompanying table for recommendations).

This content is only available via PDF.
You do not currently have access to this content.